STEPHANIE MILLER: Open Payments
NPI 1700287745 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,846 in 200 payments from 19 companies in 2025. Trend: 2023 $2,659 · 2024 $2,572 · 2025 $3,846
Food & beverage: $3,846
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $725 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 33 | $602 |
| Janssen Biotech, Inc. | 26 | $451 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $403 |
| Regeneron Healthcare Solutions, Inc. | 13 | $244 |
| Ardelyx, Inc. | 10 | $220 |
| Madrigal Pharmaceuticals | 10 | $219 |
| Lilly USA, LLC | 10 | $193 |
| PFIZER INC. | 9 | $161 |
| QOL Medical, LLC | 6 | $138 |
Products named: XIFAXAN, TREMFYA, DUPIXENT, ENTYVIO, RINVOQ, LINZESS, IBSRELA, REZDIFFRA.
Industry payments across KY — which companies pay providers there.
